Chemical formula: C₁₁H₂₁NO₃ Molecular mass: 215.293 g/mol PubChem compound: 6433083
Hexaminolevulinate blue light fluorescence cystoscopy is indicated as adjunct to standard white light cystoscopy to contribute to the diagnosis and management of bladder cancer in patients with known or high suspicion of bladder cancer.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V04CX06 | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CX Other diagnostic agents | |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| HEXVIX Powder and solvent for intravesical solution | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Hexaminolevulinate is an active ingredient of these brands:
Austria (AT)
Canada (CA)
Estonia (EE)
Finland (FI)
France (FR)
Ireland (IE)
Lithuania (LT)
New Zealand (NZ)
Poland (PL)
Spain (ES)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
